Kaya Holdings, Inc. (KAYS)
D
Pipeline Grade
Financial Position (from SEC Filings)
$0.0M
Cash & Equivalents
$0.5M
Quarterly Burn Rate
$7M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (1)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07609745 | HOME EXERCISE AND KINESIO TAPING IN NON-SPECIFIC NECK PAIN AMONG CHAIN MARKET WORKERS | OTHER | Active Not Recruiting | 30 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.